Approval process and access to prescription drugs in Canada.
暂无分享,去创建一个
L. Lynd | J. Esdaile | A. Anis | C. Marra
[1] Steve Morgan,et al. The Common Drug Review: a NICE start for Canada? , 2006, Health policy.
[2] N. Rawson. Assessing prescription medications for priority regulatory review. , 2005, Regulatory toxicology and pharmacology : RTP.
[3] S. Morgan,et al. Who's the fairest of them all? Which provincial pharmacare model would best protect Canadians against catastrophic drug costs? , 2004, Healthcare quarterly.
[4] K. Kaitin,et al. Canadian and US Drug Approval Times and Safety Considerations , 2003, The Annals of pharmacotherapy.
[5] N. Rawson. Timeliness of review and approval of new drugs in Canada from 1999 through 2001: is progress being made? , 2003, Clinical therapeutics.
[6] A. Anis,et al. A Dog’s Breakfast:: Prescription Drug Coverage Varies Widely Across Canada , 2001, Medical care.
[7] C. Violato,et al. Alberta Physician Achievement Review. , 2000, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[8] N. Rawson. Time required for approval of new drugs in Canada, Australia, Sweden, the United Kingdom and the United States in 1996-1998. , 2000, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.